» Articles » PMID: 16088195

Circulating Oxidized Low-density Lipoprotein and Paraoxonase Activity in Preeclampsia

Overview
Date 2005 Aug 10
PMID 16088195
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Preeclampsia is one of the most frequent complications of pregnancy, however, little is known about its etiology. The objective of this study was to investigate the association of oxidized low-density lipoprotein (oxLDL) and paraoxonase (PON1) activity in women with either preeclampsia or normotensive (NT) pregnancy. The study groups included 41 pregnant women with preeclampsia and 33 normotensive pregnant women. In all patients maternal serum total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglycerides (TGs) were measured using enzymatic methods. Serum PON1 activities and malondialdehyde (MDA) concentrations were measured by spectrophotometric methods, and oxLDL was measured by enzyme-linked immunoassay (ELISA). Serum concentrations of lipid parameters (TC, LDL, VLDL, and TGs) were significantly higher in preeclampsia compared with NT controls (p < 0.001, p < 0.05, p < 0.05, and p < 0.001, respectively). Serum concentrations of MDA and oxLDL were significantly higher, while PON1 activity was significantly lower in preeclampsia compared with NT controls (p < 0.001, p < 0.001, and p < 0.001, respectively). A positive correlation was detected between oxLDL and MDA (r = 0.876), and a negative correlation was detected between both MDA and oxLDL and PON1 (r = -0.837 and r = -0.759, respectively). Our data demonstrate that preeclampsia is associated with increased oxLDL and decreased PON1 activity. Elevated oxidative stress, oxLDL, dyslipidemia and decreased PON1 activities may cause vascular endothelial damage and contribute to the pathophysiology of preeclampsia.

Citing Articles

Investigating the prevalence and associated factors of elevated liver enzymes and dyslipidemia during pregnancy.

Mou A, Ali N Sci Rep. 2025; 15(1):3967.

PMID: 39893319 PMC: 11787354. DOI: 10.1038/s41598-025-88798-4.


Modified lipoprotein-induced sFlt1 production in human placental trophoblasts is mediated by protein kinase C.

Chow R, Zhao J, Li Y, Curtis T, Lyons T, Yu J Eur J Pharmacol. 2024; 986:177138.

PMID: 39551338 PMC: 11634635. DOI: 10.1016/j.ejphar.2024.177138.


Gestational diabetes mellitus, hypertension, and dyslipidemia as the risk factors of preeclampsia.

Aziz F, Khan M, Moiz A Sci Rep. 2024; 14(1):6182.

PMID: 38486097 PMC: 10940289. DOI: 10.1038/s41598-024-56790-z.


Signature precursor and mature microRNAs in cervical ripening during gestational diabetes mellitus lead to pre-term labor and other impediments in future.

Vedika R, Sharma P, Reddy A J Diabetes Metab Disord. 2023; 22(2):945-965.

PMID: 37975145 PMC: 10638342. DOI: 10.1007/s40200-023-01232-2.


The Silent Threat to Women's Fertility: Uncovering the Devastating Effects of Oxidative Stress.

Kaltsas A, Zikopoulos A, Moustakli E, Zachariou A, Tsirka G, Tsiampali C Antioxidants (Basel). 2023; 12(8).

PMID: 37627485 PMC: 10451552. DOI: 10.3390/antiox12081490.